Ambaw Bellete
President chez CG ONCOLOGY, INC.
Fortune : - $ au 30/04/2024
Profil
Ambaw Bellete currently works at OncoSTING LLC, as Chairman, Axiom REACH Foundation, as Director, and CG Oncology, Inc., as President & Chief Operating Officer from 2023.
Mr. Bellete also formerly worked at Lion Healthcare Strategies LLC, as Chief Executive Officer from 2021 to 2023, Photocure ASA, as Head-US Cancer Commercial Operations, BioNJ, Inc., as Trustee, Photocure, Inc., as President from 2012 to 2019, and FerGene, Inc., as Chief Operating Officer from 2020 to 2021.
Mr. Bellete received his undergraduate degree from Murray State University (Kentucky).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CG ONCOLOGY, INC.
-.--% | 25/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Ambaw Bellete
| Sociétés | Poste | Début |
|---|---|---|
| CG ONCOLOGY, INC. | President | 01/07/2023 |
| OncoSTING LLC | Président | - |
Anciens postes connus de Ambaw Bellete
| Sociétés | Poste | Fin |
|---|---|---|
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Directeur des opérations | 01/03/2021 |
| Photocure, Inc. | President | 01/08/2019 |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Directeur/Membre du Conseil | - |
| PHOTOCURE ASA | Corporate Officer/Principal | - |
Formation de Ambaw Bellete
| Murray State University (Kentucky) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| CG ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Photocure, Inc. | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
| OncoSTING LLC |